Provided by Tiger Trade Technology Pte. Ltd.

Mereo Biopharma Group Plc

0.2816
-0.0079-2.73%
Pre-market: 0.29000.0084+2.98%05:15 EDT
Volume:1.15M
Turnover:328.96K
Market Cap:44.81M
PE:-1.61
High:0.2926
Open:0.2880
Low:0.2810
Close:0.2895
52wk High:2.37
52wk Low:0.2000
Shares:159.13M
Float Shares:131.00M
Volume Ratio:1.29
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1753
EPS(LYR):-0.2627
ROE:-67.85%
ROA:-42.46%
PB:1.56
PE(LYR):-1.07

Loading ...

Viridis lands rare earths stalwart to drive Brazilian project

The West Australian
·
Apr 28

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading

MT Newswires Live
·
Apr 21

European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading

MT Newswires Live
·
Apr 15

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Apr 06

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 02

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Mar 30

Mereo BioPharma announced its annual general meeting

Reuters
·
Mar 27

Mereo BioPharma board changes; Annalisa Jenkins declines to stand for re-election at May 14, 2026 AGM

Reuters
·
Mar 27

Analysts Conflicted on These Healthcare Names: Erasca (ERAS) and Mereo Biopharma Group Plc (MREO)

TIPRANKS
·
Mar 26

Critica Advances Jupiter Rare Earths Project as Australia’s Largest Clay-Hosted MREO Resource

TIPRANKS
·
Mar 25

Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

TIPRANKS
·
Mar 24

Mereo BioPharma Group PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 23

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Mar 23

Mereo Biopharma Group Plc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS
·
Mar 23

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Mar 21

Mereo BioPharma Group PLC expected to post breakeven results a share - Earnings Preview

Reuters
·
Mar 20

Mereo BioPharma Group Q4 EPS $(0.01), Inline

Benzinga Earnings
·
Mar 19

UK's Mereo BioPharma misses 2025 revenue estimates, expects cash runway to mid-2027

Reuters
·
Mar 19